Blaze Bioscience, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
Expanded Access for BLZ-100 (Tozuleristide)
- First Posted Date
- 2020-04-13
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Blaze Bioscience Inc.
- Registration Number
- NCT04343274
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery
Phase 2
Completed
- Conditions
- Pediatric Central Nervous System Tumor
- Interventions
- Device: Canvas System
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Blaze Bioscience Inc.
- Target Recruit Count
- 118
- Registration Number
- NCT03579602
- Locations
- ๐บ๐ธ
Seattle Children's Hospital, Seattle, Washington, United States
๐บ๐ธChlidren's Hospital Los Angeles, Los Angeles, California, United States
๐บ๐ธJohns Hopkins University, Baltimore, Maryland, United States
Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- Blaze Bioscience Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02496065
- Locations
- ๐บ๐ธ
Overlake Medical Center, Bellevue, Washington, United States
๐บ๐ธUniversity of Washington Medical Center, Seattle, Washington, United States
Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- Blaze Bioscience Inc.
- Registration Number
- NCT02464332
- Locations
- ๐บ๐ธ
Cedars-Sinai Medical Center, Los Angeles, California, United States
Study of BLZ-100 in Pediatric Subjects With CNS Tumors
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Blaze Bioscience Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT02462629
- Locations
- ๐บ๐ธ
Seattle Children's, Seattle, Washington, United States
Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Blaze Bioscience Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT02234297
- Locations
- ๐บ๐ธ
Cedars-Sinai Medical Center, Los Angeles, California, United States
๐ฆ๐บNEWRO Foundation, Brisbane, Queensland, Australia
ยฉ Copyright 2025. All Rights Reserved by MedPath